Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Randomised phase II screening study to be used in an TPF-chemotherapy [docetaxel + cisplatin + fluorouracil] (short induction) before TPF-induction, radiotherapy with or without cetuximab in the primary therapy of the only by laryngectomy operable carcinoma of the larynx/hypopharynx. [Randomised phase II screeningstudy to be used in a TP/TPF-chemotherapy (shortinduction) before TP/TPF-induction, radiotherapy with or without cetuximab in the primary therapy of the only by laryngectomy operable carcinoma of the larynx/ hypopharynx.]

Next Previous
X
Search
Trial Profile

Randomised phase II screening study to be used in an TPF-chemotherapy [docetaxel + cisplatin + fluorouracil] (short induction) before TPF-induction, radiotherapy with or without cetuximab in the primary therapy of the only by laryngectomy operable carcinoma of the larynx/hypopharynx. [Randomised phase II screeningstudy to be used in a TP/TPF-chemotherapy (shortinduction) before TP/TPF-induction, radiotherapy with or without cetuximab in the primary therapy of the only by laryngectomy operable carcinoma of the larynx/ hypopharynx.]

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 09 May 2022

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Cetuximab (Primary) ; Cisplatin; Docetaxel; Fluorouracil
  • Indications Laryngeal cancer
  • Focus Therapeutic Use
  • Acronyms DeLOS II

    • Most Recent Events

    • 01 Oct 2018 Results published in the Annals of Oncology
    • 07 Jun 2016 Results presented at the 52nd Annual Meeting of the American Society of Clinical Oncology
    • 25 Apr 2015 Status changed from active, no longer recruiting to completed, as reported by European Clinical Trials Database record.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top